Flexible Sigmoidoscopy in the Randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial: Added Yield from a Second Screening Examination
Joel L. Weissfeld(University of Pittsburgh), Robert S. Bresalier(The University of Texas MD Anderson Cancer Center), V. Paul Doria‐Rose(National Cancer Institute), Philip C. Prorok(National Cancer Institute), Timothy R. Church(University of Minnesota), Paul F. Pinsky(National Cancer Institute), Lois Lamerato(Henry Ford Health System), Claudine Isaacs(Georgetown University), Robert E. Schoen(University of Pittsburgh Medical Center), Saundra S. Buys(University of Utah), Lance Yokochi(National Institutes of Health), E. David Crawford(University of Colorado Denver), Adeyinka O. Laiyemo(Howard University), Douglas J. Reding(Ascension), Joshua Rathmell(Georgetown University), Christine D. Berg(United States Department of Health and Human Services), Susan Yurgalevitch(United States Department of Health and Human Services), G. L. Andriole(Washington University in St. Louis), Mona Fouad(United States Department of Health and Human Services)
Cited by 40
Related Papers
Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood
|New England Journal of Medicine|1993|3.3k
Mortality Results from a Randomized Prostate-Cancer Screening Trial
|New England Journal of Medicine|2009|2.9k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer
|New England Journal of Medicine|2003|2.6k